DIGEMID — Discontinuidad de Medicamentos (Peru) (DIGEMID)

DIGEMID — Discontinuidad de Medicamentos (Peru) is the official source of medicine shortage information for Peru (Latin America). Mederti checks its register regularly and links every notice back to the original publication.

Official register

serviciosweb-digemid.minsa.gob.pe

Country

Peru

Notices tracked by Mederti

1,649

Last checked

2 Aug 2026

Latest notices from DIGEMID

• Clotrimazolo — active, medium, since 31 Mar 2027 (source)
• Clorhidrato De Ambroxol — active, medium, since 5 Mar 2027 (source)
• Fosfato Dipotasico — active, medium, since 1 Oct 2026 (source)
• N-L-Alanil-L-Glutamina — active, medium, since 31 Aug 2026 (source)
• Clorhidrato De Ambroxol — active, medium, since 23 Aug 2026 (source)
• Burosumab(10 Mg/Ml),Burosumab(20 Mg/Ml),Burosumab(30 Mg/Ml),Darbepoetin Alfa(10 Μg),Darbepoetin Alfa(120 Μg),Darbepoetin Alfa(180 Μg),Darbepoetin Alfa(20 Μg),Darbepoetin Alfa(30 Μg),Darbepoetin Alfa(40 Μg),Darbepoetin Alfa(60 Μg),Romiplostim 375 Μg/Vial(250 Μg/Vial (Deliverable Amount)) — active, medium, since 24 Jul 2026 (source)
• Acetilcisteina — active, medium, since 10 Jul 2026 (source)
• Gemfibrozilo — active, medium, since 6 Jul 2026 (source)
• Dexametasona Kern Pharma — active, medium, since 20 Jun 2026 (source)
• Clorhidrato De Ambroxol — active, medium, since 20 Jun 2026 (source)
• Acido Clavulanico + Amoxicillina — active, medium, since 20 Jun 2026 (source)
• Clorhidrato De Ambroxol — active, medium, since 18 Jun 2026 (source)
• Metotrexato Sodico — active, medium, since 15 Jun 2026 (source)
• Paclitaxel — active, medium, since 8 Jun 2026 (source)
• Candesartan Cilexetil — active, medium, since 1 Jun 2026 (source)

Mederti is not affiliated with or endorsed by DIGEMID — Discontinuidad de Medicamentos (Peru). All notices remain the property of their publisher and are linked to the original source.